(NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a
U.S. Securities and Exchange Commission (
SEC) filing by Santarus Inc. (Form 8-K) was posted ...
[Published NewsRX - May 17 2013]